Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
Stocks in this Quantisnow insightHealth Care
Historical context for REVB
Across the 11 sessions after earlier REVB headlines, the stock closed higher 2 times and lower 9 times, with a median move of 1.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | REVB | SPY |
|---|---|---|---|
| Feb 27, 2026 | Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025 | -0.8% | -0.5% |
| Jan 26, 2026 | Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026 | -14.9% | +0.5% |
| Jan 23, 2026 | Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds | -24.4% | +0.0% |
| Jan 21, 2026 | Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI | -10.1% | +1.2% |
| Jan 14, 2026 | Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) | -0.6% | -0.5% |
| Jan 13, 2026 | Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | +0.6% | -0.2% |
Quantisnow market dataNASDAQ
REVB
Revelation Biosciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for REVB
Full REVB profile on Quantisnow Follow REVB and get a push notification the moment its next story breaks.